HL7 Terminology (THO)
6.0.2 - Publication
HL7 Terminology (THO)
6.0.2 - Publication
This page is part of the HL7 Terminology (v6.0.2: Release) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
| Active as of 2019-03-20 |
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="v3-substanceAdminSubstitution"/>
<language value="en"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><p class="res-header-id"><b>Generated Narrative: CodeSystem v3-substanceAdminSubstitution</b></p><a name="v3-substanceAdminSubstitution"> </a><a name="hcv3-substanceAdminSubstitution"> </a><a name="v3-substanceAdminSubstitution-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Language: en</p></div><p><b>Properties</b></p><p><b>This code system defines the following properties for its concepts</b></p><table class="grid"><tr><td><b>Name</b></td><td><b>Code</b></td><td><b>URI</b></td><td><b>Type</b></td><td><b>Description</b></td></tr><tr><td>Specializes</td><td>Specializes</td><td/><td>Coding</td><td>The child code is a more narrow version of the concept represented by the parent code. I.e. Every child concept is also a valid parent concept. Used to allow determination of subsumption. Must be transitive, irreflexive, antisymmetric.</td></tr><tr><td>Generalizes</td><td>Generalizes</td><td/><td>Coding</td><td>Inverse of Specializes. Only included as a derived relationship.</td></tr><tr><td>internalId</td><td>internalId</td><td>http://terminology.hl7.org/CodeSystem/utg-concept-properties#v3-internal-id</td><td>code</td><td>The internal identifier for the concept in the HL7 Access database repository.</td></tr><tr><td>Not Selectable</td><td>notSelectable</td><td>http://hl7.org/fhir/concept-properties#notSelectable</td><td>boolean</td><td>Indicates that the code is abstract - only intended to be used as a selector for other concepts</td></tr><tr><td>Status</td><td>status</td><td>http://hl7.org/fhir/concept-properties#status</td><td>code</td><td>Designation of a concept's state. Normally is not populated unless the state is retired.</td></tr></table><p><b>Concepts</b></p><p>This case-sensitive code system <code>http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution</code> defines the following codes in a Is-A hierarchy:</p><table class="codes"><tr><td><b>Lvl</b></td><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td><td><b>internalId</b></td><td><b>Not Selectable</b></td><td><b>Status</b></td></tr><tr><td>1</td><td style="white-space:nowrap">_ActSubstanceAdminSubstitutionCode<a name="v3-substanceAdminSubstitution-_ActSubstanceAdminSubstitutionCode"> </a></td><td>ActSubstanceAdminSubstitutionCode</td><td><div><p>Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.</p>
</div></td><td>21284</td><td>true</td><td>active</td></tr><tr><td>2</td><td style="white-space:nowrap"> E<a name="v3-substanceAdminSubstitution-E"> </a></td><td>equivalent</td><td><div><p>Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.</p>
</div></td><td>23107</td><td/><td>active</td></tr><tr><td>3</td><td style="white-space:nowrap"> EC<a name="v3-substanceAdminSubstitution-EC"> </a></td><td>equivalent composition</td><td><div><p>Substitution occurred or is permitted with another product that is a:</p>
<ul>
<li>pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester</li>
<li>pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration</li>
</ul>
<p><em>Examples:</em></p>
<ul>
<li><em>Pharmaceutical alternative:</em> Erythromycin Ethylsuccinate for Erythromycin Stearate</li>
<li><em>Pharmaceutical equivalent:</em> Lisonpril for Zestril</li>
</ul>
</div></td><td>23108</td><td/><td>active</td></tr><tr><td>4</td><td style="white-space:nowrap"> BC<a name="v3-substanceAdminSubstitution-BC"> </a></td><td>brand composition</td><td><div><p>Substitution occurred or is permitted between equivalent Brands but not Generics</p>
<p><em>Examples:</em></p>
<ul>
<li>Zestril for Prinivil</li>
<li>Coumadin for Jantoven</li>
</ul>
</div></td><td>23109</td><td/><td>active</td></tr><tr><td>4</td><td style="white-space:nowrap"> G<a name="v3-substanceAdminSubstitution-G"> </a></td><td>generic composition</td><td><div><p>Substitution occurred or is permitted between equivalent Generics but not Brands</p>
<p><em>Examples:</em></p>
<ul>
<li>Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)</li>
</ul>
</div></td><td>16623</td><td/><td>active</td></tr><tr><td>3</td><td style="white-space:nowrap"> TE<a name="v3-substanceAdminSubstitution-TE"> </a></td><td>therapeutic alternative</td><td><div><p>Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.</p>
<p><em>Examples:</em></p>
<ul>
<li>ranitidine for Tagamet</li>
</ul>
</div></td><td>16624</td><td/><td>active</td></tr><tr><td>4</td><td style="white-space:nowrap"> TB<a name="v3-substanceAdminSubstitution-TB"> </a></td><td>therapeutic brand</td><td><div><p>Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics</p>
<blockquote>
</blockquote>
<p><em>Examples:</em></p>
<ul>
<li>Zantac for Tagamet</li>
</ul>
</div></td><td>23105</td><td/><td>active</td></tr><tr><td>4</td><td style="white-space:nowrap"> TG<a name="v3-substanceAdminSubstitution-TG"> </a></td><td>therapeutic generic</td><td><div><p>Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands</p>
<blockquote>
</blockquote>
<p><em>Examples:</em></p>
<ul>
<li>Ranitidine for cimetidine</li>
</ul>
</div></td><td>23106</td><td/><td>active</td></tr><tr><td>2</td><td style="white-space:nowrap"> F<a name="v3-substanceAdminSubstitution-F"> </a></td><td>formulary</td><td><div><p>This substitution was performed or is permitted based on formulary guidelines.</p>
</div></td><td>16625</td><td/><td>active</td></tr><tr><td>2</td><td style="white-space:nowrap"> N<a name="v3-substanceAdminSubstitution-N"> </a></td><td>none</td><td><div><p>No substitution occurred or is permitted.</p>
</div></td><td>16622</td><td/><td>active</td></tr></table></div>
</text>
<url
value="http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution"/>
<identifier>
<system value="urn:ietf:rfc:3986"/>
<value value="urn:oid:2.16.840.1.113883.5.1070"/>
</identifier>
<version value="3.0.0"/>
<name value="SubstanceAdminSubstitution"/>
<title value="Substance Admin Substitution"/>
<status value="active"/>
<experimental value="false"/>
<date value="2019-03-20"/>
<publisher value="Health Level Seven International"/>
<contact>
<telecom>
<system value="url"/>
<value value="http://hl7.org"/>
</telecom>
<telecom>
<system value="email"/>
<value value="hq@HL7.org"/>
</telecom>
</contact>
<description
value="Identifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided."/>
<copyright
value="This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html"/>
<caseSensitive value="true"/>
<hierarchyMeaning value="is-a"/>
<content value="complete"/>
<property>
<extension
url="http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-symmetry">
<valueCode value="antisymmetric"/>
</extension>
<extension
url="http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-transitivity">
<valueCode value="transitive"/>
</extension>
<extension
url="http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-reflexivity">
<valueCode value="irreflexive"/>
</extension>
<extension
url="http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-isNavigable">
<valueBoolean value="true"/>
</extension>
<extension
url="http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-relationshipKind">
<valueCode value="Specializes"/>
</extension>
<extension
url="http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-inverseName">
<valueString value="Generalizes"/>
</extension>
<code value="Specializes"/>
<description
value="The child code is a more narrow version of the concept represented by the parent code. I.e. Every child concept is also a valid parent concept. Used to allow determination of subsumption. Must be transitive, irreflexive, antisymmetric."/>
<type value="Coding"/>
</property>
<property>
<extension
url="http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-symmetry">
<valueCode value="antisymmetric"/>
</extension>
<extension
url="http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-transitivity">
<valueCode value="transitive"/>
</extension>
<extension
url="http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-reflexivity">
<valueCode value="irreflexive"/>
</extension>
<extension
url="http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-isNavigable">
<valueBoolean value="true"/>
</extension>
<extension
url="http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-relationshipKind">
<valueCode value="Generalizes"/>
</extension>
<extension
url="http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-inverseName">
<valueString value="Specializes"/>
</extension>
<code value="Generalizes"/>
<description
value="Inverse of Specializes. Only included as a derived relationship."/>
<type value="Coding"/>
</property>
<property>
<code value="internalId"/>
<uri
value="http://terminology.hl7.org/CodeSystem/utg-concept-properties#v3-internal-id"/>
<description
value="The internal identifier for the concept in the HL7 Access database repository."/>
<type value="code"/>
</property>
<property>
<code value="notSelectable"/>
<uri value="http://hl7.org/fhir/concept-properties#notSelectable"/>
<description
value="Indicates that the code is abstract - only intended to be used as a selector for other concepts"/>
<type value="boolean"/>
</property>
<property>
<code value="status"/>
<uri value="http://hl7.org/fhir/concept-properties#status"/>
<description
value="Designation of a concept's state. Normally is not populated unless the state is retired."/>
<type value="code"/>
</property>
<concept>
<code value="_ActSubstanceAdminSubstitutionCode"/>
<display value="ActSubstanceAdminSubstitutionCode"/>
<definition
value="Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects."/>
<property>
<code value="notSelectable"/>
<valueBoolean value="true"/>
</property>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
<property>
<code value="internalId"/>
<valueCode value="21284"/>
</property>
<concept>
<code value="E"/>
<display value="equivalent"/>
<definition
value="Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product."/>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
<property>
<code value="internalId"/>
<valueCode value="23107"/>
</property>
<concept>
<code value="EC"/>
<display value="equivalent composition"/>
<definition
value="Substitution occurred or is permitted with another product that is a:
* pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
* pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration
*Examples:*
* *Pharmaceutical alternative:* Erythromycin Ethylsuccinate for Erythromycin Stearate
* *Pharmaceutical equivalent:* Lisonpril for Zestril"/>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
<property>
<code value="internalId"/>
<valueCode value="23108"/>
</property>
<concept>
<code value="BC"/>
<display value="brand composition"/>
<definition
value="Substitution occurred or is permitted between equivalent Brands but not Generics
*Examples:*
* Zestril for Prinivil
* Coumadin for Jantoven"/>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
<property>
<code value="internalId"/>
<valueCode value="23109"/>
</property>
</concept>
<concept>
<code value="G"/>
<display value="generic composition"/>
<definition
value="Substitution occurred or is permitted between equivalent Generics but not Brands
*Examples:*
* Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)"/>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
<property>
<code value="internalId"/>
<valueCode value="16623"/>
</property>
</concept>
</concept>
<concept>
<code value="TE"/>
<display value="therapeutic alternative"/>
<definition
value="Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.
*Examples:*
* ranitidine for Tagamet"/>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
<property>
<code value="internalId"/>
<valueCode value="16624"/>
</property>
<concept>
<code value="TB"/>
<display value="therapeutic brand"/>
<definition
value="Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics
>
*Examples:*
* Zantac for Tagamet"/>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
<property>
<code value="internalId"/>
<valueCode value="23105"/>
</property>
</concept>
<concept>
<code value="TG"/>
<display value="therapeutic generic"/>
<definition
value="Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands
>
*Examples:*
* Ranitidine for cimetidine"/>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
<property>
<code value="internalId"/>
<valueCode value="23106"/>
</property>
</concept>
</concept>
</concept>
<concept>
<code value="F"/>
<display value="formulary"/>
<definition
value="This substitution was performed or is permitted based on formulary guidelines."/>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
<property>
<code value="internalId"/>
<valueCode value="16625"/>
</property>
</concept>
<concept>
<code value="N"/>
<display value="none"/>
<definition value="No substitution occurred or is permitted."/>
<property>
<code value="status"/>
<valueCode value="active"/>
</property>
<property>
<code value="internalId"/>
<valueCode value="16622"/>
</property>
</concept>
</concept>
</CodeSystem>
IG © 2020+ HL7 International - Vocabulary Work Group. Package hl7.terminology#6.0.2 based on FHIR 5.0.0. Generated 2024-07-21
Links: Table of Contents |
QA Report
| Version History 
|
|
Propose a change